What investigations should be done to exclude neurosyphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Investigations to Exclude Neurosyphilis

To exclude neurosyphilis, perform a lumbar puncture with CSF examination including CSF-VDRL, white blood cell count with differential, and protein level—a nonreactive CSF treponemal test (such as FTA-ABS) effectively rules out neurosyphilis. 1, 2

When to Perform CSF Examination

The CDC recommends lumbar puncture in the following clinical scenarios: 3, 1

  • Neurologic or ocular symptoms/signs (headache, visual disturbances, altered mental status, cranial nerve deficits)
  • Active tertiary syphilis (aortitis, gumma, iritis)
  • Treatment failure for non-neurologic syphilis
  • HIV-infected patients with late-latent syphilis or syphilis of unknown duration
  • Some specialists recommend CSF examination for all HIV-infected patients with syphilis, particularly if serum RPR ≥1:32 or CD4+ count <350 cells/µL 3, 4

Essential CSF Tests

CSF-VDRL (Primary Diagnostic Test)

  • Highly specific (99-100%) but insensitive (49-87%) for neurosyphilis 5, 6
  • A reactive CSF-VDRL is diagnostic of neurosyphilis (assuming no significant blood contamination) 3, 1, 5
  • A nonreactive CSF-VDRL does NOT exclude neurosyphilis due to limited sensitivity 3, 5

CSF White Blood Cell Count

  • CSF WBC >10 cells/µL combined with reactive CSF-VDRL strongly supports neurosyphilis 3, 1, 2
  • Typical range in neurosyphilis: 10-200 cells/µL with mononuclear predominance 3, 2
  • Critical caveat: HIV infection itself can cause mild pleocytosis (5-15 cells/µL), particularly with CD4+ counts >500 cells/µL, complicating interpretation 3, 2

CSF Protein

  • Usually normal or mildly elevated in neurosyphilis 3, 1, 2
  • Never base diagnosis solely on elevated CSF protein without reactive VDRL or elevated WBC 3, 2

CSF Treponemal Tests (FTA-ABS or TPPA)

  • Highly sensitive (100%) but not specific (12-13% specificity) 3, 4
  • A nonreactive CSF treponemal test excludes neurosyphilis 3, 1
  • A reactive test does NOT confirm neurosyphilis 3, 1

Diagnostic Algorithm

Step 1: Perform CSF-VDRL, WBC count, protein, and consider CSF treponemal test 1, 5, 2

Step 2: Interpret results:

  • Reactive CSF-VDRL + CSF WBC >10 cells/µL = Neurosyphilis confirmed 3, 1, 2
  • Nonreactive CSF treponemal test = Neurosyphilis excluded 3, 1
  • Nonreactive CSF-VDRL but elevated WBC or protein = Cannot exclude neurosyphilis; consider treatment if clinical suspicion high 3

Step 3: If neurosyphilis cannot be excluded by nonreactive treponemal test, treat empirically for neurosyphilis 3

Serum Testing Limitations

  • Serum RPR/VDRL titers do NOT diagnose or exclude neurosyphilis 5, 4
  • Serum RPR titers were not associated with early neurosyphilis in HIV-infected patients 4
  • However, serum RPR >1:32 may increase suspicion and warrant CSF examination 3, 7

Critical Pitfalls to Avoid

  • Blood contamination during lumbar puncture can cause false-positive CSF-VDRL results 5, 2
  • Do not rely on CSF protein elevation alone without other CSF abnormalities 3, 2
  • In HIV-infected patients, adjust interpretation for baseline HIV-related pleocytosis; some use >20 cells/µL as the threshold rather than >10 cells/µL 4
  • PCR-based methods are NOT recommended for neurosyphilis diagnosis 3
  • Calculated indices (TPHA-index) have limited value and should not guide diagnosis 3

Additional Considerations

  • False-negative serologic tests can occur in HIV-infected patients; if clinical suspicion is high despite negative serology, pursue other diagnostic procedures 1
  • Neuroimaging (MRI or CT) may show abnormalities but is not diagnostic; imaging is essential to demonstrate structural findings and aid in differential diagnosis 8

References

Guideline

Diagnosing and Treating Neurosyphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

CSF Findings in Neurosyphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnóstico y Seguimiento de Neurosífilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Imaging features of neurosyphilis.

Journal of neuroradiology = Journal de neuroradiologie, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.